BRAF and melanoma: Different from sporadic microsatellite instable colorectal cancer, MSI-GCs lack BRAF-mutations (Cancer Genome Atlas Research 2014) and BRAF cannot be used as predictive biomarker like in malignant melanomas (Warneke et al. 2013a, b).